Evidence map›Paper›PMID 26499836›Full record

ArticleMolecular & cellular proteomics : MCP2016

Comparative Phosphoproteomics Reveals the Role of AmpC β-lactamase Phosphorylation in the Clinical Imipenem-resistant Strain Acinetobacter baumannii SK17.

Juo-Hsin Lai, Jhih-Tian Yang, Jeffy Chern, Te-Li Chen, Wan-Ling Wu, Jiahn-Haur Liao, Shih-Feng Tsai, Suh-Yuen Liang, Chi-Chi Chou, Shih-Hsiung Wu

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Exploration of Phosphoproteins inPathogens (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Review
  7. Colistin Resistance inAntibiotics (Basel, Switzerland) · 2023
    Review
  8. Article
  9. Pathogens (Basel, Switzerland) · 2021
    Review
  10. Review
  11. Phosphorylation of Extracellular Proteins inFrontiers in microbiology · 2021
    Article
  12. Bacterial Protein Kinases.Advances in experimental medicine and biology · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Goals and Challenges in Bacterial Phosphoproteomics.International journal of molecular sciences · 2019
    Review
  17. Article
  18. Acetylome ofFrontiers in molecular biosciences · 2017
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Juo-Hsin LaiFrom the ‡Institute of Biochemical Sciences, College of Life Sciences, National Taiwan University, Taipei 10617, Taiwan; §Institute of Biological Chemistry, Academia Sinica. Taipei 11529, Taiwan;
Jhih-Tian Yang§Institute of Biological Chemistry, Academia Sinica. Taipei 11529, Taiwan; ¶Ph.D. Program in Microbial Genomics, National Chung Hsing University and Academia Sinica, Taiwan;
Jeffy Chern§Institute of Biological Chemistry, Academia Sinica. Taipei 11529, Taiwan; ‖Chemical Biology and Molecular Biophysics Program, Taiwan International Graduate Program, Academia Sinica, Taipei 11529, Taiwan; **Department of Chemistry, National Taiwan University, Taipei 10617, Taiwan;
Te-Li Chen‡‡Institute of Clinical Medicine, School of Medicine, National Yang Ming University, Taipei 11221, Taiwan; §§Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei 11217, Taiwan; ¶¶Department of Medicine, Cheng Hsin General Hospital, Taipei 11220, Taiwan;
Wan-Ling Wu§Institute of Biological Chemistry, Academia Sinica. Taipei 11529, Taiwan;
Jiahn-Haur Liao§Institute of Biological Chemistry, Academia Sinica. Taipei 11529, Taiwan;
Shih-Feng Tsai‖‖Department of Life Sciences and Institute of Genome Sciences, National Yang-Ming University, Taipei 11221, Taiwan; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli 35053, Taiwan;
Suh-Yuen Liang§Institute of Biological Chemistry, Academia Sinica. Taipei 11529, Taiwan; Core Facilities for Protein Structural Analysis, Institute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan.
Chi-Chi Chou§Institute of Biological Chemistry, Academia Sinica. Taipei 11529, Taiwan; Core Facilities for Protein Structural Analysis, Institute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan.
Shih-Hsiung WuFrom the ‡Institute of Biochemical Sciences, College of Life Sciences, National Taiwan University, Taipei 10617, Taiwan; §Institute of Biological Chemistry, Academia Sinica. Taipei 11529, Taiwan; ‖Chemical Biology and Molecular Biophysics Program, Taiwan International Graduate Program, Academia Sinica, Taipei 11529, Taiwan; **Department of Chemistry, National Taiwan University, Taipei 10617, Taiwan; shwu@gate.sinica.edu.tw.ORCID http://orcid.org/0000-0002-1490-1227
Institute of Biological Chemistry, Academia Sinica · TWNational Taiwan University · TWAcademia Sinica · TWGenomics Research Center, Academia Sinica · TWNational Health Research Institutes · TWNational Yang Ming Chiao Tung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nosocomial infectious outbreaks caused by multidrug-resistant Acinetobacter baumannii have emerged as a serious threat to human health. Phosphoproteomics of pathogenic bacteria has been used to identify the mechanisms of bacterial virulence and antimicrobial resistance. In this study, we used a shotgun strategy combined with high-accuracy mass spectrometry to analyze the phosphoproteomics of the imipenem-susceptible strain SK17-S and -resistant strain SK17-R. We identified 410 phosphosites on 248 unique phosphoproteins in SK17-S and 285 phosphosites on 211 unique phosphoproteins in SK17-R. The distributions of the Ser/Thr/Tyr/Asp/His phosphosites in SK17-S and SK17-R were 47.0%/27.6%/12.4%/8.0%/4.9% versus 41.4%/29.5%/17.5%/6.7%/4.9%, respectively. The Ser-90 phosphosite, located on the catalytic motif S(88)VS(90)K of the AmpC β-lactamase, was first identified in SK17-S. Based on site-directed mutagenesis, the nonphosphorylatable mutant S90A was found to be more resistant to imipenem, whereas the phosphorylation-simulated mutant S90D was sensitive to imipenem. Additionally, the S90A mutant protein exhibited higher β-lactamase activity and conferred greater bacterial protection against imipenem in SK17-S compared with the wild-type. In sum, our results revealed that in A. baumannii, Ser-90 phosphorylation of AmpC negatively regulates both β-lactamase activity and the ability to counteract the antibiotic effects of imipenem. These findings highlight the impact of phosphorylation-mediated regulation in antibiotic-resistant bacteria on future drug design and new therapies.

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasesbeta-Lactam ResistanceBinding SitesCross InfectionHumansImipenemModels, MolecularMutationPhosphoproteinsPhosphorylationProtein Structure, TertiaryProteomeProteomicsAmpC beta-lactamasesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesImipenemPhosphoproteinsProteome

Identifiers

PMID26499836
PMCPMC4762518
OpenAlexW2175601366

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.